Search Results - "Zacks, Steven"

Refine Results
  1. 1

    The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease by Kim, Hannah P., Navarro, Victor, Zacks, Steven, Odin, Joseph, Kleiner, David E., Hayashi, Paul H.

    Published in Clinical gastroenterology and hepatology (01-10-2021)
    “…Oxaliplatin is an alkylating agent given with fluorouracil and leucovorin as a mainstay adjuvant chemotherapy for stage III colorectal cancer (CRC). Liver…”
    Get full text
    Journal Article
  2. 2

    Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response by Feld, Jordan J., Nanda, Santosh, Huang, Ying, Chen, Weiping, Cam, Maggie, Pusek, Susan N., Schweigler, Lisa M., Theodore, Dickens, Zacks, Steven L., Liang, T. Jake, Fried, Michael W.

    Published in Hepatology (Baltimore, Md.) (01-11-2007)
    “…The reasons for hepatitis C treatment failure remain unknown but may be related to different host responses to therapy. In this study, we compared hepatic gene…”
    Get full text
    Journal Article
  3. 3

    Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates by Fallon, Michael B, Krowka, Michael J, Brown, Robert S, Trotter, James F, Zacks, Steven, Roberts, Kari E, Shah, Vijay H, Kaplowitz, Neil, Forman, Lisa, Wille, Keith, Kawut, Steven M

    Published in Gastroenterology (New York, N.Y. 1943) (01-10-2008)
    “…Background & Aims: Hepatopulmonary syndrome (HPS) affects 10%–30% of patients with cirrhosis and portal hypertension, but the impact on functional status,…”
    Get full text
    Journal Article
  4. 4

    Clinical risk factors for portopulmonary hypertension by Kawut, Steven M., Krowka, Michael J., Trotter, James F., Roberts, Kari E., Benza, Raymond L., Badesch, David B., Taichman, Darren B., Horn, Evelyn M., Zacks, Steven, Kaplowitz, Neil, Brown, Robert S., Fallon, Michael B.

    Published in Hepatology (Baltimore, Md.) (01-07-2008)
    “…Portopulmonary hypertension affects up to 6% of patients with advanced liver disease, but the predictors and biologic mechanism for the development of this…”
    Get full text
    Journal Article
  5. 5

    Race, insulin resistance and hepatic steatosis in chronic hepatitis C by Conjeevaram, Hari S., Kleiner, David E., Everhart, Jay E., Hoofnagle, Jay H., Zacks, Steven, Afdhal, Nezam H., Wahed, Abdus S.

    Published in Hepatology (Baltimore, Md.) (01-01-2007)
    “…Hepatic steatosis is common in chronic hepatitis C and has been linked to concurrent obesity, insulin resistance, diabetes, disease severity, and poor response…”
    Get full text
    Journal Article
  6. 6

    A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy by Zacks, Steven L, Sandler, Robert S, Rutledge, Robert, Brown, Robert S

    “…OBJECTIVES: Laparoscopic cholecystectomy (LC) has become a popular alternative to open cholecystectomy (OC). Previous studies comparing outcomes in LC and OC…”
    Get full text
    Journal Article
  7. 7

    Pantoprazole reduces the size of postbanding ulcers after variceal band ligation : A randomized, controlled trial by SHAHEEN, Nicholas J, STUART, Eugene, SCHMITZ, Sarah M, MITCHELL, Kate L, FRIED, Michael W, ZACKS, Steven, RUSSO, Mark W, GALANKO, Joseph, SHRESTHA, Roshan

    Published in Hepatology (Baltimore, Md.) (01-03-2005)
    “…Elective esophageal variceal ligation (EVL) is performed to decrease the risk of variceal hemorrhage. Side effects of EVL include hemorrhage, chest pain,…”
    Get full text
    Journal Article
  8. 8

    A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy by Zacks, Steven L, Sandler, Robert S, Rutledge, Robert, Brown, Robert S

    Published in The American journal of gastroenterology (01-02-2002)
    “…Laparoscopic cholecystectomy (LC) has become a popular alternative to open cholecystectomy (OC). Previous studies comparing outcomes in LC and OC used small…”
    Get full text
    Journal Article
  9. 9

    Serotonin transporter polymorphisms in patients with portopulmonary hypertension by Roberts, Kari E, Fallon, Michael B, Krowka, Michael J, Benza, Raymond L, Knowles, James A, Badesch, David B, Brown, Jr, Robert S, Taichman, Darren B, Trotter, James, Zacks, Steven, Horn, Evelyn M, Kawut, Steven M

    Published in Chest (01-06-2009)
    “…The long allele of a functional promoter polymorphism in the serotonin transporter (SERT) is associated with an increased risk of some forms of pulmonary…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Oral budesonide for the therapy of post‐liver transplant de novo inflammatory bowel disease: A case series and systematic review of the literature by Barritt, A. Sidney, Zacks, Steven L., Rubinas, Tara C., Herfarth, Hans H.

    Published in Inflammatory bowel diseases (01-12-2008)
    “…Background: The therapy for posttransplant IBD is clinically challenging. Patients receiving liver transplants are immunosuppressed to prevent rejection, but…”
    Get full text
    Journal Article
  12. 12

    Impact of Donor Age and Year of Transplant on Graft Survival in Liver Transplant Recipients with Chronic Hepatitis C by Russo, Mark W., Galanko, Joseph A., Zacks, Steven L., Beavers, Kimberly L., Fried and, Michael W., Shrestha, Roshan

    Published in American journal of transplantation (01-07-2004)
    “…Studies suggest donor age and year of transplantation are associated with low graft survival in liver transplant recipients with hepatitis C. We sought to…”
    Get full text
    Journal Article
  13. 13

    Region 11 MELD Na exception prospective study by Fisher, Robert A, Heuman, Douglas M, Harper, Ann M, Behnke, Martha K, Smith, Alastair D, Russo, Mark W, Zacks, Steven, McGillicuddy, John W, Eason, James, Porayko, Michael K, Northup, Patrick, Marvin, Michael R, Hundley, Johnathan, Nair, Satheesh

    Published in Annals of hepatology (01-01-2012)
    “…Hyponatremia complicates cirrhosis and predicts short term mortality, including adverse outcomes before and after liver transplantation. From April 1, 2008,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study by Chalasani, Naga, Bonkovsky, Herbert L, Fontana, Robert, Lee, William, Stolz, Andrew, Talwalkar, Jayant, Reddy, K. Rajendar, Watkins, Paul B, Navarro, Victor, Barnhart, Huiman, Gu, Jiezhun, Serrano, Jose

    Published in Gastroenterology (New York, N.Y. 1943) (01-06-2015)
    “…Background & Aims The Drug-Induced Liver Injury Network is conducting a prospective study of patients with DILI in the United States. We present…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Management of newly diagnosed hepatitis C virus infection by Russo, Mark W, Zacks, Steven L, Fried, Michael W

    Published in Cleveland Clinic journal of medicine (01-09-2003)
    “…All patients with chronic hepatitis C virus infection are potential candidates for antiviral therapy. Careful patient selection can optimize the response to…”
    Get full text
    Journal Article
  19. 19

    Kupffer cell and interleukin‐12–dependent loss of natural killer T cells in hepatosteatosis by Kremer, Michael, Thomas, Emmanuel, Milton, Richard J., Perry, Ashley W., van Rooijen, Nico, Wheeler, Michael D., Zacks, Steven, Fried, Michael, Rippe, Richard A., Hines, Ian N.

    Published in Hepatology (Baltimore, Md.) (01-01-2010)
    “…Hepatosteatosis is associated with increased expression of tumor necrosis factor alpha (TNF‐α) and interleukin (IL)‐12, major T helper (Th) 1 cytokines, and…”
    Get full text
    Journal Article
  20. 20